WHICH OBESITY SURGERY? WHY SLEEVE GASTRECTOMY?

WHAT ARE THE ADVANTAGES OF SLEEVE GASTRECTOMY?

*The gastric transition tract is narrowed. Sensation of fullness is achieved with a few bite food.

*The secretion of the appetite hormone(ghrelin) decreases. Appetite is suppressed.

*Balanced nutrition is possible. Patients can eat everything, but only small portion.

*Natural passage of foods in the gastrointestinal tract is preserved.

*The rate of complication and side-effect is relatively low.

*It ensures loss of majority of excessive weight in a period of one year.

♣Comparing to the Gastric Bypass - (another surgery carried out for obesity)

-Complications faced in gastric bypass surgery secondary to partial bypass of the small intestine are not observed in the sleeve gastrectomy.

-Sleeve Gastrectomy is a simpler procedure and operation time is shorter than Gastric Bypass.

♣Sleeve Gastrectomy is superior to the Gastric Plication regarding the effectiveness and the comfort. In gastric plication, residual gastric structure can be variable, while a standard form and volume can be created by the sleeve gastrectomy.

♣In gastric band surgery, which is another surgical procedure for obesity treatment, a silicone band remains permanently in the abdominal region for many years. Sleeve gastrectomy surgery does not have such a problem.

♣Sleeve gastrectomy can be converted to some other obesity surgeries, if necessary.

WHAT ARE THE DISADVANTAGES OF SLEEVE GASTRECTOMY?

-A large part of the stomach is removed. It is not possible to convert the stomach to its natural form.

- The potential of weight loss may decrease in patients who enjoy high-calorie fluids and sugary foods.

-The stomach that is given a tube form may expand slightly over the time, and accordingly, the weight loss effect may decrease over the years.

-This surgery requires more technological equipment comparing to the gastric plication.

-It has become a commonly used surgery within the last decade. The ten-year results are very successful in a very large group of patients, while the long-term follow-up outcomes are not clear yet.